Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 9,issue 4  (01-2009)

Period of time： 2009年4期

Publisher： Bentham Science Publishers

Founded in： 2001

Total resources： 51

E-ISSN： 2212-3873|9|4

ISSN： 1871-5303

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 9,issue 4

Menu

Immune Cell Entry to Central Nervous System - Current Understanding and Prospective Therapeutic Targets

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 9,issue 4 , Vol. 9, Iss. 4, 2009-12 , pp. 315-327

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Dendritic Cells for Active Anti-Cancer Immunotherapy: Targeting Activation Pathways Through Genetic Modification

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 9,issue 4 , Vol. 9, Iss. 4, 2009-12 , pp. 328-343

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

MHC Class I TCR Engineered Anti-Tumor CD4 T Cells: Implications For Cancer Immunotherapy

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 9,issue 4 , Vol. 9, Iss. 4, 2009-01 , pp. 344-352

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Interleukin-24: A Molecule with Potential Anti-Cancer Activity and a Cytokine in Search of a Function

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 9,issue 4 , Vol. 9, Iss. 4, 2009-12 , pp. 353-360

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Synergistic Activation of Leukocytes by Bacterial Chemoattractants: Potential Drug Targets

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 9,issue 4 , Vol. 9, Iss. 4, 2009-01 , pp. 361-370

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Future Developments in Osteoporosis Therapy

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 9,issue 4 , Vol. 9, Iss. 4, 2009-01 , pp. 371-384

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Pleiotropic Effects of Cathepsin D

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 9,issue 4 , Vol. 9, Iss. 4, 2009-01 , pp. 385-391

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

A Current Update on the Use of Alpha Lipoic Acid in the Management of Type 2 Diabetes Mellitus

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 9,issue 4 , Vol. 9, Iss. 4, 2009-12 , pp. 392-398

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Total 8 item(s)